Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study
Background: The role of rivaroxaban in patients with heart failure (HF) combined with left ventricular (LV) thrombus remains unknown in current guideline-directed anticoagulant therapy. The aim of this study was to investigate the impact on clinical outcomes of rivaroxaban compared to vitamin K anta...
Main Authors: | Qian Zhang, Zhongfan Zhang, Haikuo Zheng, Ming Qu, Shouping Li, Ping Yang, Daoyuan Si, Wenqi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1008031/full |
Similar Items
-
Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation
by: Qian Zhang, et al.
Published: (2023-07-01) -
Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
by: Lei Huang, et al.
Published: (2022-10-01) -
Factors influencing left ventricular thrombus resolution and its significance on clinical outcomes
by: Se‐Eun Kim, et al.
Published: (2023-06-01) -
Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta‐analysis
by: Dhan B. Shrestha, et al.
Published: (2023-11-01) -
Time Trends of Etiology, Treatment, and Long-Term Outcomes Among Patients with Left Ventricular Thrombus
by: Boqun Shi, et al.
Published: (2023-10-01)